Unlock Healthcare Overview
Unlock.Healthcare mission is to deliver personalized therapies, guided by real-time health data and advanced digital support. By leveraging biomarker insights and AI-driven care, the company adapts each treatment to fit the individual’s unique biology and evolving health needs. The platform enables patients to select tailored solutions, seamlessly connect with healthcare providers, and track their progress with our advanced digital caregiver app. Unlock.Healthcare is revolutionizing medicine by shifting from generic treatments to truly personalized care, empowering patients and providers to achieve better outcomes together
Cumulative Funding Raised Over Time ($)
Latest News
growth-positive
Unlock.Healthcare: Personalizing Medicine with Plants, AI, and Purpose
Unlock.Healthcare is an Israel-based digital health platform that leverages AI technology and plant-based therapies to offer personalized medicine. Founded by the Segal brothers, the company was inspired by their fathers experience with chronic pain and opioid dependency. Unlock.Healthcare provides a comprehensive intake and biomarker analysis to create individualized treatment plans, including cannabinoid medicine and lifestyle support. The platform features a digital caregiver that monitors patient responses in real time. The company is expanding its operations in Europe, Israel, and South America, with plans to enter North America. Unlock.Healthcare collaborates with universities, biotech companies, and patient advocacy groups to contribute to a global data ecosystem. The company emphasizes ethics, sustainability, and user empowerment, positioning itself at the forefront of the personalized medicine movement.
PartnersExpand
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $1M |
| Last funding | $1M |
| Stage | Pre-Seed |
| Rounds | 1 |
| Investors | 0 |
Team Members
2
Employees: 11-50
Web & Social Links
| Website | unlock-healthcare.com |
Locations
Yigal Alon St 126, Tel Aviv-Yafo, Israel
Photos & Videos
No files yet
